Xilio Therapeutics

XLONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$60.294 M

$9.17 -1.08%

Close of 7 Aug 2026

Revenue

$43.8M

#2787 by revenue

Earnings

-$35.0M

Loss-making

Shares outstanding

5,782,511

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#342MindWalkHYFT$61.2M
#343Dogwood TherapeuticsDWTX$60.7M
#344Xilio TherapeuticsXLO$60.3M
#345IntercureINCR$58.0M
#346ImmutepIMMP$56.8M

Where these numbers come from

Share counts and financials for Xilio Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.